EUVIMEDEUVIMED entdecken
Fallbericht

High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction–Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation

Jin Ho Lee, Heeryong Lee, Kipyo Kim, Seoung Woo Lee, Joon Ho Song, Seun Deuk Hwang

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.01.031 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Jin Ho Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Leesin Hemodialysis and Intervention Clinic, Busan, South Korea. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunoglobulins, Intravenous, Polyomavirus Infections, BK Virus. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Inha University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: ABO-incompatible (ABOi) transplantation is a novel method transplantation method that carries a heightened risk of infection caused by the use of high immunosuppressant doses. This elevated risk is particularly concerning for viral infections, such as cytomegalovirus (CMV) and the BK virus (BKV) increases. Herein, we present a case where high-dose intravenous immunoglobulin (IVIG) was effective in treating viral infections after transplantation. METHODS: A 41-year-old man underwent an ABOi transplantation. The initial isoagglutinin titer was 1:32. The patient received 200 mg of rituximab, and 3 rounds of plasmapheresis were performed. Subsequently, renal function remained normal; however, 7 months later, the renal function declined, and BK nephropathy and CMV infection were diagnosed through biopsy and serologic tests. The FK level was reduced, and mycophenolate mofetil was discontinued. Although ciprofloxacin and leflunomide were administered, their effects were minimal. Therefore, high-dose IVIG (1 g/kg) was administered 5 times over 5 weeks, which led to a reduction in BK viral load and CMV infectivity in the serum. CONCLUSIONS: High-dose IVIG may serve as a promising alternative treatment to mitigate early transplant rejection and BKV and CMV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunoglobulins, IntravenousPolyomavirus InfectionsBK VirusTumor Virus InfectionsCytomegalovirus InfectionsAntilymphocyte SerumHumansMaleAdultABO Blood-Group SystemImmunosuppressive AgentsBlood Group Incompatibility

Substanzen

Immunoglobulins, IntravenousAntilymphocyte SerumABO Blood-Group SystemImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Leesin Hemodialysis and Intervention Clinic, Busan, South Korea.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, Inha University College of Medicine, Incheon, South Korea.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, Inha University College of Medicine, Incheon, South Korea. Electronic address: lakisis79@hanmail.net.

Förderung

  • Inha University

Zitieren

APA

Lee, J. H., Lee, H., Kim, K., Lee, S. W., Song, J. H., & Hwang, S. D. (2024). High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction–Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.01.031

Vancouver

Lee JH, Lee H, Kim K, Lee SW, Song JH, Hwang SD. High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction–Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.01.031

BibTeX
@article{Lee2024,
  author = {Lee, Jin Ho and Lee, Heeryong and Kim, Kipyo and Lee, Seoung Woo and Song, Joon Ho and Hwang, Seun Deuk},
  title = {High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction–Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.01.031}
}
Kostenlos starten →